跳至主要内容
临床试验/JPRN-UMIN000017006
JPRN-UMIN000017006已完成未知

Effect on Insulin Resistance in Tofogliflozin-treated Japanese Type 2 diabetic patients - Tofogliflozin and insulin sensitivity

Matsuba Medical Clinic0 个研究点目标入组 15 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Has hypersensitivity to tofogliflozin or any other excipient of tofogliflozin 2) With severe ketosis, diabetic coma, or precoma within 6 months 3) With severe infection, pre or post surgery, and serious trauma 4) With severe renal dysfunction 5) With severe liver dysfunction 6) Entered already with another clinical trials (7) Considered as inadequate by the investigator

研究者

发起方
Matsuba Medical Clinic

相似试验